Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9623)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 15, 2020 (publication date) through Apr 1, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang J, Tan SB, Guo ZG. CD47 decline in pancreatic islet cells promotes macrophage-mediated phagocytosis in type I diabetes. World J Diabetes 2020; 11(6): 239-251 [PMID: 32547698 DOI: 10.4239/wjd.v11.i6.239] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v11/i6/239.htm |
| Number | Citing Articles |
| 1 |
Kaiyven Afi Leslie, Sarah J. Richardson, Mark A. Russell, Noel G. Morgan. Expression of CD47 in the pancreatic β‐cells of people with recent‐onset type 1 diabetes varies according to disease endotype. Diabetic Medicine 2021; 38(12) doi: 10.1111/dme.14724
|
| 2 |
Victoria C. Brom, Christof Burger, Dieter C. Wirtz, Frank A. Schildberg. The Role of Immune Checkpoint Molecules on Macrophages in Cancer, Infection, and Autoimmune Pathologies. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.837645
|
| 3 |
Xi Su, Wenwen Jin, Lizhi Liu, Zifei Zhu, Cunyan Li. Regulation of CD47 expression on CD14+ monocytes by interferon-α in PBC patients. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1256995
|
| 4 |
Wencheng Zhang, Shuo Yang, Xinwen Yu, Shanshan Zhu, Xin Wang, Fei Sun, Shengru Liang, Xiaoguang Wang, Guohong Zhao, Bin Gao. Beneficial Actions of 4-Methylumbelliferone in Type 1 Diabetes by Promoting β Cell Renewal and Inhibiting Dedifferentiation. Biomedicines 2024; 12(12): 2790 doi: 10.3390/biomedicines12122790
|
| 5 |
Shuang Yang, Ming Zhao, Sujie Jia. Macrophage: Key player in the pathogenesis of autoimmune diseases. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1080310
|
| 6 |
Jeffrey S. Isenberg, Enrique Montero. Tolerating CD47. Clinical and Translational Medicine 2024; 14(2) doi: 10.1002/ctm2.1584
|
| 7 |
Wei-Qing Deng, Zi-Han Ye, Zhenghai Tang, Xiao-Lei Zhang, Jin-Jian Lu. Beyond cancer: The potential application of CD47-based therapy in non-cancer diseases. Acta Pharmaceutica Sinica B 2025; 15(2): 757 doi: 10.1016/j.apsb.2024.11.018
|
| 8 |
Henriette Reventlow Frederiksen, Alexandra Glantz, Kåre Kryger Vøls, Søren Skov, Pernille Tveden-Nyborg, Kristine Freude, Ulrik Doehn. CRISPR-Cas9 immune-evasive hESCs are rejected following transplantation into immunocompetent mice. Frontiers in Genome Editing 2024; 6 doi: 10.3389/fgeed.2024.1403395
|
| 9 |
David D. Roberts, Jeffrey S. Isenberg. CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes. American Journal of Physiology-Cell Physiology 2021; 321(2): C201 doi: 10.1152/ajpcell.00175.2021
|
| 10 |
Robert C. Sharp, Matthew E. Brown, Melanie R. Shapiro, Amanda L. Posgai, Todd M. Brusko. The Immunoregulatory Role of the Signal Regulatory Protein Family and CD47 Signaling Pathway in Type 1 Diabetes. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.739048
|